20
Ranbaxy Laboratories Limited Gurgaon In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Fluoxetine hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1999-178 - Rev 01
This Chemical Type CEP, issued on September 27, 2006, remains in force until December 20, 2012, ensuring its reliability within the pharmaceutical industry.
Substance Number 1104 associated with this CEP further emphasizes